Clinical Trial Update: Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravenous L-Citrulline in children undergoing heart bypass surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Pulmonary Hypertension

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Heart Defects, Congenital, Hypertension, Pulmonary | Phase 3 | Status: COMPLETED